Using passenger mutations to estimate the timing of driver mutations and identify mutator alterations

BMC Bioinformatics

Volumn 14, Issue 1, 2013, Pages

  Youn, Ahrim ^a   Simon, Richard ^a  

^a NATIONAL CANCER INSTITUTE   (United States)

Author keywords

Estimating the order of mutations during tumorigenesis; Identifying mutator genes; Probabilistic modeling of tumor development

Indexed keywords

ALTERATION RATES; CHROMOSOMAL REGIONS; COPY NUMBER DATUM; GENOMIC ALTERATIONS; GENOMIC INSTABILITY; RESEARCH EFFORTS; TUMOR DEVELOPMENT; TUMORIGENESIS;

DIGITAL STORAGE; DNA SEQUENCES; ESTIMATION; TUMORS;

GENES;

ARTICLE; BIOLOGICAL MODEL; BIOLOGY; CELL TRANSFORMATION; DNA SEQUENCE; GENETICS; HUMAN; METHODOLOGY; MUTATION; NEOPLASM;

CELL TRANSFORMATION, NEOPLASTIC; COMPUTATIONAL BIOLOGY; HUMANS; MODELS, GENETIC; MUTATION; NEOPLASMS; SEQUENCE ANALYSIS, DNA;

EID: 84890005211     PISSN: None     EISSN: 14712105     Source Type: Journal    
DOI: 10.1186/1471-2105-14-363     Document Type: Article

References (32)

1. Vogelstein B, Papadopoulos N, Velculescu VE, Zhou S, Diaz LA, Kinzler KW. Cancer Genome landscapes. Science 2013, 339(6127):1546-1558. 10.1126/science.1235122, 3749880, 23539594.
2. Yachida S, Jones S, Bozic I, Antal T, Leary R, Fu B, Kamiyama M, Hruban RH, Eshleman JR, Nowak MA, Velculescu VE, Kinzler KW, Vogelstein B, Iacobuzio-Donahue CA. Distant metastasis occurs late during the genetic evolution of pancreatic cancer. Nature 2010, 467(7319):1114-1117. 10.1038/nature09515, 3148940, 20981102.
3. Weinberg RA. The Biology of Cancer, 1st edn. 2006, Garland Science.
4. Gatenby RA, Maini PK. Mathematical oncology: cancer summed up. Nature 2003, 421(6921):321. http://dx.doi.org/10.1038/421321a, 10.1038/421321a, 12540881.
5. Desper R, Jiang F, Kallioniemi OP, Branch CG, Moch H, Papadimitriou CH, Schaffer AA. Inferring tree models for oncogenesis from comparative genome hybridization data. J Comput Biol 1999, 6:37-51. 10.1089/cmb.1999.6.37, 10223663.
6. Attolini CSO, Cheng YK, Beroukhim R, Getz G, Abdel-Wahab O, Levine RL, Mellinghoff IK, Michor F. A mathematical framework to determine the temporal sequence of somatic genetic events in cancer. Proc Natl Acad Sci 2010, http://www.pnas.org/content/early/2010/09/17/1009117107.abstract.
7. Durinck S, Ho C, Wang NJ, Liao W, Jakkula LR, Collisson EA, Pons J, Chan SW, Lam ET, Chu C, Park K, Hong S, Hur JS, Huh N, Neuhaus IM, Yu SS, Grekin RC, Mauro TM, Cleaver JE, Kwok PY, LeBoit PE, Getz G, Cibulskis K, Aster JC, Huang H, Purdom E, Li J, Bolund L, Arron ST, Gray JW, Spellman PT, Cho RJ. Temporal dissection of tumorigenesis in primary cancers. Cancer Discov 2011, 1(2):137-143. http://dx.doi.org/10.1158/2159-8290.CD-11-0028, 10.1158/2159-8290.CD-11-0028, 3187561, 21984974.
8. Gerstung M, Eriksson N, Lin J, Vogelstein B, Beerenwinkel N. The temporal order of genetic and pathway alterations in tumorigenesis. PLoS ONE 2011, 6(11):e27136. http://www.plosone.org/article/info%3Adoi%2F10.1371%2Fjournal.pone.0027136, 10.1371/journal.pone.0027136, 3206070, 22069497.
9. Youn A, Simon R. Estimating the order of mutations during tumorigenesis from tumor genome sequencing data. Bioinformatics 2012, 28(12):1555-1561. http://bioinformatics.oxfordjournals.org/content/28/12/1555.abstract, 10.1093/bioinformatics/bts168, 3465102, 22492649.
10. Negrini S, Gorgoulis VG, Halazonetis TD. Genomic instability - an evolving hallmark of cancer. Nature Rev Mol Cell Biol 2010, 11(3):220-228.
11. Lengauer C, Kinzler KW, Vogelstein B. Genetic instabilities in human cancers. Nature 1998, 396(6712):643-649. http://dx.doi.org/10.1038/25292, 10.1038/25292, 9872311.
12. Loeb LA. A mutator phenotype in cancer. Cancer Res 2001, 61(8):3230-3239. http://cancerres.aacrjournals.org/content/61/8/3230.abstract.
13. Loeb LA, Loeb KR, Anderson JP. Multiple mutations and cancer. Proc Natl Acad Sci USA 2003, 100(3):776-781. http://dx.doi.org/10.1073/pnas.0334858100, 10.1073/pnas.0334858100, 298677, 12552134.
14. Youn A, Simon R. Identifying cancer driver genes in tumor genome sequencing studies. Bioinformatics 2011, 27(2):175-181. http://dx.doi.org/10.1093/bioinformatics/btq630, 10.1093/bioinformatics/btq630, 3018819, 21169372.
15. Olshen AB, Venkatraman ES, Lucito R, Wigler M. Circular binary segmentation for the analysis of array-based DNA copy number data. Biostatistics 2004, 5(4):557-572. http://view.ncbi.nlm.nih.gov/pubmed/15475419, 10.1093/biostatistics/kxh008, 15475419.
16. Mermel CH, Schumacher SE, Hill B, Meyerson ML, Beroukhim R, Getz G. GISTIC2.0 facilitates sensitive and confident localization of the targets of focal somatic copy-number alteration in human cancers. Genome Biol 2011, 12(4):R41. http://www.biomedsearch.com/nih/GISTIC20-facilitates-sensitive-confident-localization/21527027.html, 10.1186/gb-2011-12-4-r41, 3218867, 21527027.
17. Lichtenauer-Kaligis EG, Thijssen J, den Dulk H, de Jong JGT, Giphart-Gassler M, van de Putte P Comparison of spontaneous hprt mutation spectra at the nucleotide sequence level in the endogenous hprt gene and five other genomic positions. Mut Res/Fundam Mol Mech Mutagen 1996, 351(2):147-155. http://www.sciencedirect.com/science/article/pii/0027510795002197, van de Putte P.
18. Araten DJ, Golde DW, Zhang RH, Thaler HT, Gargiulo L, Notaro R, Luzzatto L. A quantitative measurement of the human somatic mutation rate. Cancer Res 2005, 65(18):8111-8117. http://www.biomedsearch.com/nih/quantitative-measurement-human-somatic-mutation/16166284.html, 10.1158/0008-5472.CAN-04-1198, 16166284.
19. Cancer Genome Atlas Research Network Integrated genomic analyses of ovarian carcinoma. Nature 2011, 474(7353):609-615. http://dx.doi.org/10.1038/nature10166, 10.1038/nature10166, 3163504, 21720365, Cancer Genome Atlas Research Network.
20. Yoshida K, Miki Y. Role of BRCA1 and BRCA2 as regulators of DNA repair, transcription, and cell cycle in response to DNA damage. Cancer Sci 2004, 95(11):866-871. 10.1111/j.1349-7006.2004.tb02195.x, 15546503.
21. Cheng Y, Liu W, Kim ST, Sun J, Lu L, Sun J, Zheng SL, Isaacs WB, Xu J. Evaluation of {PPP2R2A} as a prostate cancer susceptibility gene: a comprehensive germline and somatic study. Cancer Genet 2011, 204(7):375-381. http://www.sciencedirect.com/science/article/pii/S2210776211001190, 10.1016/j.cancergen.2011.05.002, 3722858, 21872824.
22. Kalev P, Simicek M, Vazquez I, Munck S, Chen L, Soin T, Danda N, Chen W, Sablina A. Loss of PPP2R2A Inhibits Homologous Recombination DNA Repair and Predicts Tumor Sensitivity to PARP Inhibition. Cancer Res 2012, 72(24):6414-6424. http://cancerres.aacrjournals.org/content/72/24/6414.abstract, 10.1158/0008-5472.CAN-12-1667, 23087057.
23. Phelan K, McDermid H. The 22q13.3 deletion syndrome (Phelan-McDermid Syndrome). Mol Syndromol 2012, 2(3-5):186-201. 3366702, 22670140.
24. Murnane JP. Telomere loss as a mechanism for chromosome instability in human cancer. Cancer Res 2010,, 0008-5472.CAN-09-4357+. http://dx.doi.org/10.1158/0008-5472.can-09-4357.
25. Maser RS, Depinho RA. Connecting chromosomes, crisis, and cancer. Science 2002, 297(5581):565-569. 10.1126/science.297.5581.565, 12142527.
26. Ding L, Getz G, Wheeler DA, Mardis ER, Mclellan MD, Cibulskis K, Sougnez C, Greulich H, Muzny DM, Morgan MB, Fulton L, Fulton RS, Zhang Q, Wendl MC, Lawrence MS, Larson DE, Chen K, Dooling DJ, Sabo A, Hawes AC, Shen H, Jhangiani SN, Lewis LR, Hall O, Zhu Y, Mathew T, Ren Y, Yao J, Scherer SE, Clerc K, et al. Somatic mutations affect key pathways in lung adenocarcinoma. Nature 2008, 455(7216):1069-1075. http://dx.doi.org/10.1038/nature07423, 10.1038/nature07423, 2694412, 18948947.
27. Liu CX, Li Y, Obermoeller-McCormick LM, Schwartz AL, Bu G. The putative tumor suppressor LRP1B, a novel member of the Low Density Lipoprotein (LDL) receptor family, exhibits both overlapping and distinct properties with the LDL receptor-related protein. J Biol Chem 2001, 276(31):28889-28896. http://www.jbc.org/content/276/31/28889.abstract, 10.1074/jbc.M102727200, 11384978.
28. Lambert S, Harwood C, Purdie K, Gulati A, Matin R, Romanowska M, Cerio R, Kelsell D, Leigh I, Proby C. Metastatic cutaneous squamous cell carcinoma shows frequent deletion in the protein tyrosine phosphatase receptor Type D gene. Int J Cancer 2012, 131(3):E216-E226. 10.1002/ijc.27333, 22052591.
29. Tomasetti C, Vogelstein B, Parmigiani G. Half or more of the somatic mutations in cancers of self-renewing tissues originate prior to tumor initiation. Proc Natl Acad Sci 2013, 110(6):1999-2004. http://www.pnas.org/content/110/6/1999.abstract, 10.1073/pnas.1221068110, 3568331, 23345422.
30. Stripp BR, Reynolds SD. Maintenance and repair of the bronchiolar epithelium. Proc Am Thoracic Soc 2008, 5(3):328-333.
31. Tinnemans M, Schutte B, Lenders M, Ten Velde G, Ramaekers F, Blijham G. Cytokinetic analysis of lung cancer by in vivo bromodeoxyuridine labelling. Br J Cancer 1993, 67(6):1217-1222. 10.1038/bjc.1993.228, 1968512, 8512806.
32. Griffith O, Gray J. Omic approaches to preventing or managing metastatic breast cancer. Breast Cancer Res 2011, 13(6):230. http://breast-cancer-research.com/content/13/6/230, 10.1186/bcr2923, 3326544, 22216753.